Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation
- 25 May 2022
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 101, 14-20
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve ImplantationAmerican Heart Journal, 2016
- Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve ReplacementJACC, 2015
- Incidence and Predictors of Debris Embolizing to the Brain During Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2015
- SAT-TAVI (single antiplatelet therapy for TAVI) study: A pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantationInternational Journal of Cardiology, 2014
- Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitalsNetherlands Heart Journal, 2013
- Guideline on the management of bleeding in patients on antithrombotic agentsBritish Journal of Haematology, 2012
- Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2011
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- Acquired von Willebrand Syndrome in Aortic StenosisNew England Journal of Medicine, 2003